Related Experiment Video
Updated: May 14, 2026

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
Carbapenem-resistant Gram-negative bacteria: how to prioritize infection prevention and control interventions in
Anucha Apisarnthanarak1, Li Yang Hsu, Thana Khawcharoenporn
1Division of Infectious Diseases, Faculty of Medicine, Thammasat University Hospital, Pathumthani, 12120, Thailand. anapisarn@yahoo.com
Abstract:
Emergences of carbapenem-resistant Gram-negative bacteria (CRGNB) have heightened global awareness of the prioritization of infection prevention and control (IPC) interventions to minimize infections attributed to these bacteria. Effective new antibiotic drugs for CRGNB are estimated to be at least 5 years off completion of trials and approval for use. Hence, effective IPC strategies remain at the core of clinical care and research for patients with CRGNB infection. The authors summarize current evidence and viewpoints for IPC strategies as related to the emergence, transmission and prevention of CRGNB.
Insights
Carbapenem-resistant Gram-negative bacteria (CRGNB) require urgent infection prevention and control (IPC) strategies. As new antibiotics are years away, effective IPC remains crucial for managing CRGNB infections and limiting their spread.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- The rise of carbapenem-resistant Gram-negative bacteria (CRGNB) presents a significant global health challenge.
- Existing antibiotic treatments are becoming increasingly ineffective against these multidrug-resistant organisms.
Purpose of the Study:
- To review and synthesize current evidence and expert opinions on infection prevention and control (IPC) strategies for CRGNB.
- To highlight the importance of IPC in the absence of new effective antibiotic therapies.
Main Methods:
- Systematic review of existing literature on CRGNB.
- Synthesis of current viewpoints on IPC strategies.
- Analysis of emergence, transmission, and prevention data.
Main Results:
- Effective new antibiotic drugs for CRGNB are projected to be at least 5 years from approval.
- IPC strategies are identified as the primary means of managing CRGNB infections.
- Evidence and viewpoints on critical IPC measures are summarized.
Conclusions:
- Robust IPC interventions are paramount for controlling the spread of CRGNB.
- Continued research and clinical focus on IPC are essential for patient care and public health.
- A multi-faceted approach to IPC is necessary to combat CRGNB emergence and transmission.
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Acute Pyelonephritis II: Diagnostic Studies and Management
Clinical Significance of Antibiotic Resistance
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
